JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2003; 41:1831-1837, doi:10.1016/S0735-1097(03)00340-1
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kumar, K.
Right arrow Articles by Verrier, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumar, K.
Right arrow Articles by Verrier, R. L.

BASIC SCIENCE

Potent antifibrillatory effects of intrapericardial nitroglycerin in the ischemic porcine heart

Kapil Kumar, MD*, Khanh Nguyen, BA{dagger}, Sergio Waxman, MD*{dagger}, Bruce D. Nearing, PhD*{dagger}, Gregory A. Wellenius, MSc{ddagger}, Susan X. Zhao, MS* and Richard L. Verrier, PhD, FACC*{dagger}{ddagger},*

* Harvard Medical School, Boston, Massachusetts, USA
{dagger} Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
{ddagger} Harvard School of Public Health, Boston, Massachusetts, USA

Manuscript received August 23, 2002; revised manuscript received December 19, 2002, accepted January 16, 2003.

* Reprint requests and correspondence: Dr. Richard L. Verrier, Beth Israel Deaconess Medical Center, One Autumn Street, Kennedy Building, 5th Floor, Boston, Massachusetts 02215, USA.
rverrier{at}bidmc.harvard.edu

OBJECTIVES: We investigated the antiarrhythmic effects of intrapericardial nitroglycerin (NTG) during acute myocardial ischemia in the porcine heart.

BACKGROUND: Nitroglycerin is a nitric oxide donor that exerts potent effects on the cardiovascular system. Intrapericardial administration allows investigation of pharmacologic actions on cardiac tissue in an in vivo system while minimizing the confounding influences of systemic effects.

METHODS: In 29 closed-chest pigs, myocardial ischemia was induced by intraluminal balloon occlusion of the left anterior descending coronary artery. Arrhythmia incidence was monitored during 5-min balloon inflations performed without drug and at 15, 45, 75, and 105 min after NTG (4,000 µg bolus) administered by percutaneous transatrial access into the pericardial space. Electrocardiograms were monitored for ischemia-induced T-wave alternans (TWA), a marker of electrical instability. The antiadrenergic potential of NTG was investigated by examining the drug’s suppression of dobutamine-induced increase in myocardial contractility.

RESULTS: Control coronary artery occlusion provoked ventricular fibrillation (VF) in all animals. Intrapericardial NTG suppressed VF at 45 min in all six pigs (p < 0.05) and reduced TWA across a parallel time course (from 459.1 ± 144.4 µV before drug to 42.22 ± 13.96 µV at 45 min, p = 0.047). The antifibrillatory effect occurred as early as 15 min and persisted for up to 75 min. Augmentation of maximum of the first time derivative of left ventricular pressure by dobutamine was blunted by intrapericardial NTG (from 3,999 ± 196 mm Hg/s before NTG to 3,543 ± 220 mm Hg/s at 15 min, p = 0.012).

CONCLUSIONS: Intrapericardial NTG exerts a robust antifibrillatory action. Potential mechanisms include reduction in electrical instability and blunting of adrenergic effects.

Abbreviations and Acronyms
  cGMP
  cyclic guanine monophosphate
  ECG
  electrocardiogram
  HR
  heart rate
  LAD
  left anterior descending coronary artery
  LV
  left ventricle/ventricular
  LV dP/dt max
  maximum of the first time derivative of left ventricular pressure
  NO
  nitric oxide
  NTG
  nitroglycerin
  SBP
  systolic blood pressure
  TWA
  T-wave alternans
  VF
  ventricular fibrillation
  VPB
  ventricular premature beat




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
D. R. Gonzalez, F. Beigi, A. V. Treuer, and J. M. Hare
Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes
PNAS, December 18, 2007; 104(51): 20612 - 20617.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. E. Brack, V. H. Patel, J. H. Coote, and G. A. Ng
Nitric oxide mediates the vagal protective effect on ventricular fibrillation via effects on action potential duration restitution in the rabbit heart
J. Physiol., September 1, 2007; 583(2): 695 - 704.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2003 by the American College of Cardiology Foundation.